Sugi Predict

Sugi Predict / Compounds / SCHEMBL29386277

SCHEMBL29386277

SCHEMBL29386277

O=C(N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)OCc1ccccc1

nearest known ligand 0.76

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ NMBR P28336 2/20 0.76
▸ MAPT P10636 2/20 0.71
▸ GAA P10253 1/20 0.71
▸ HTT P42858 1/20 0.71
▸ LMNA P02545 1/20 0.69
▸ ECE1 P42892 4/20 0.69
▸ MME P08473 3/20 0.69
▸ ACE P12821 2/20 0.65
▸ CASP1 P29466 1/20 0.64
▸ SSTR1 P30872 1/20 0.63
▸ ALOX15 P16050 1/20 0.63
▸ LNPEP Q9UIQ6 1/20 0.63
▸ CA2 P00918 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29401760 1.00 NMBR (0.76) NMBRMAPTGAAHTTLMNA
SCHEMBL1285921 1.00 NMBR (0.76) NMBRMAPTGAAHTTLMNA
SCHEMBL29935468 1.00 NMBR (0.76) NMBRMAPTGAAHTTLMNA
SCHEMBL220800 1.00 NMBR (0.76) NMBRMAPTGAAHTTLMNA
SCHEMBL3808330 1.00 NMBR (0.76) NMBRMAPTGAAHTTLMNA
SCHEMBL14595066 0.96 NMBR (0.76) NMBRMAPTGAAHTTLMNA
SCHEMBL5403959 0.94 MME (0.69) NMBRMAPTGAAHTTLMNA
SCHEMBL31326046 0.94 NMBR (0.74) NMBRMAPTGAAHTTLMNA
SCHEMBL29401161 0.93 NMBR (0.76) NMBRMAPTGAAHTTLMNA
SCHEMBL3265534 0.93 NMBR (0.76) NMBRMAPTGAAHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121575079-A SGLT1/2 double-target inhibitor, screening method and application thereof, and diabetes treatment drug 广东药科大学 2026-02-27 — — CN claimed
CN-114133398-B Amino acid substituted acyclovir tricyclic nucleoside derivative and synthesis method and application thereof 中南民族大学 2022-11-22 — — CN claimed
CN-114133398-A Amino acid substituted acyclovir tricyclic nucleoside derivative and synthesis method and application thereof 中南民族大学 2022-03-04 — — CN claimed
EP-4748846-A1 METHOD FOR SYNTHESIZING AMIDE AND/OR POLYPEPTIDE BY TAKING TRANSIENTLY PROTECTED AMINO ACID AS AMMONIA COMPONENT GUANGZHOU MEDICAL UNIVERSITY (CN) 2026-05-27 — — EP disclosed
US-12570673-B2 c-Myc protein inhibitor, and preparation method therefor and use thereof SUZHOU KINTOR PHARMACEUTICALS, INC. (CN) 2026-03-10 — — US disclosed
CN-121575079-A SGLT1/2 double-target inhibitor, screening method and application thereof, and diabetes treatment drug 广东药科大学 2026-02-27 — — CN disclosed
US-20260001907-A1 Method for Synthesizing Amide and/or Polypeptide Using Transient Protected Amino Acid as Ammonia Component UNIV GUANGZHOU MEDICAL (CN) 2026-01-01 — — US disclosed
CN-121064470-A Corrosion inhibition polymer for acidizing and fracturing, corrosion inhibitor composition and preparation method thereof 中国石油天然气股份有限公司 2025-12-05 — — CN disclosed
EP-4622991-A2 SYNTHESIS OF A CYCLIC PEPTIDE Janssen Pharmaceutica NV (BE) 2025-10-01 — — EP disclosed
WO-2025068607-A1 MODULAR ARMADILLO REPEAT PROTEINS Universität Zürich (CH) 2025-04-03 — — WO disclosed
CN-119613701-A Method for synthesizing functionalized polyether in multi-proton system 华南理工大学 2025-03-14 — — CN disclosed
CN-114133398-B Amino acid substituted acyclovir tricyclic nucleoside derivative and synthesis method and application thereof 中南民族大学 2022-11-22 — — CN disclosed
US-20220324884-A1 C-MYC PROTEIN INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF SUZHOU KINTOR PHARMACEUTICALS, INC. (CN) 2022-10-13 — — US disclosed
CN-115053184-A Composition for forming EUV resist underlayer film 日产化学株式会社 2022-09-13 — — CN disclosed
US-20220283131-A1 COMPOSITION FOR DETECTING OR MEASURING ANALYTES BERTIS CO., LTD. (KR) 2022-09-08 — — US disclosed
CN-112430199-B Acetylenic amide mediated thioester compound preparation method 江西师范大学 2022-04-12 — — CN disclosed
US-20220089522-A1 METHOD OF PREPARING A DON PRODRUG FROM L-GLUTAMIC ACID DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), AS COLLATERAL AGENT 2022-03-24 — — US disclosed
WO-2022050529-A1 COMPOSITION FOR DETECTING OR MEASURING ANALYTE ㈜베르티스 2022-03-10 — — WO disclosed
CN-114133398-A Amino acid substituted acyclovir tricyclic nucleoside derivative and synthesis method and application thereof 中南民族大学 2022-03-04 — — CN disclosed
CN-114072413-A C-Myc protein inhibitor and preparation method and application thereof 苏州开拓药业股份有限公司 2022-02-18 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220089522-A1 METHOD OF PREPARING A DON PRODRUG FROM L-GLUTAMIC ACID GLUL, GLRA1, GRIN1 NMBR 1354/4885MAPT 3832/4885GAA 287/4885
US-12570673-B2 c-Myc protein inhibitor, and preparation method therefor and use thereof MYC, MYCBP, TP53 NMBR 3964/4885MAPT 488/4885GAA 3068/4885
US-20260001907-A1 Method for Synthesizing Amide and/or Polypeptide Using Transient Protected Amino Acid as Ammonia Component BCAT1, BCAT2, VIP NMBR 3409/4885MAPT 4794/4885GAA 1696/4885
US-20220324884-A1 C-MYC PROTEIN INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF MYC, MYCBP, MYCBP2 NMBR 2645/4885MAPT 642/4885GAA 3216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.